ProBiotix Health announces new commercial partnership in Greece with consumer brand specialist Eifron

ProBiotix Health Plc (‘ProBiotix’), a life sciences company developing probiotics to support cardiometabolic health, has strengthened its global footprint by cementing a commercial partnership with Eifron SA (‘Eifron’), a consumer brand specialist based in Greece.

As part of the alliance, Eifron will introduce YourBiotixBP, containing ProBiotix’s proprietary IP protected probiotic strain LPLDL®, to its existing probiotic consumer brand portfolio.

It is anticipated that initial products will be launched in the first quarter of 2025 in Greece and other selected regions in Europe. The strategic partnership will enable Eifron to expand its range by including a product for cholesterol and blood pressure lowering, with the possibility of adding other products from ProBiotix in future.  

Elias Kartasiadis, CEO of Eifron, added: “We are thrilled to partner with ProBiotix Health and bring their scientifically-backed products to our markets. This partnership aligns perfectly with our mission to provide our customers with effective and natural health solutions.

“We believe this collaboration will help us expand our reach and offer differentiation and added value to the growing group of consumers looking to improve their cardiometabolic health,” Kartasiadis added.

Founded in 2011, Eifron specialises in innovative healthcare solutions and holds a strong market position, particularly in Greece where it is among the top five brands in the country.

Its core focus is addressing unmet medical needs by developing and distributing advanced product solutions for the health sector, with particularly close ties among pharmacies and healthcare professionals. Eifron’s current product portfolio includes pharmaceuticals, supplements, and medical devices.

Steen Andersen, CEO of ProBiotix, commented: “This exceptional opportunity to work with a science-driven market leader like Eifron represents another significant milestone in our efforts to expand our reach and broaden the availability of our innovative cardiometabolic health product solutions in Europe.

“Eifron’s reputation and expertise in the health sector, and their commitment to natural solutions, makes them an ideal partner for us.”

For more information on ProBiotix Health, visit https://probiotixhealth.com.

Latest RNS News

Our commitment to ongoing technology, research and scientific development ensures you’ll always stay ahead in the probiotic field.

YourBiotixBP product image
news-header-01